Basis: Trailing twelve months (TTM net income over TTM revenue). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the net profit margin high or low?
The net profit margin of -13.36% is in line with its 5-year average of -13.79%, around the middle of its 5-year range (-37.01%–1.18%).
24.16% below its 12-month average of -10.76%.
Reported quarterly profit margin; no daily interpolation. Q2 FY2026 (2026-06-30): -2.17%.
NET PROFIT MARGIN
-13.36%
NET PROFIT MARGIN AVG TTM
-10.76%
NET PROFIT MARGIN AVG 3Y
-9.31%
NET PROFIT MARGIN AVG 5Y
-13.79%
NET PROFIT MARGIN AVG 10Y
-18.63%
NET PROFIT MARGIN AVG 15Y
-25.59%
NET PROFIT MARGIN AVG 20Y
-48.40%
CURRENT VS TTM AVG
-24.16%
CURRENT VS 3Y AVG
-43.44%
CURRENT VS 5Y AVG
+3.15%
CURRENT VS 10Y AVG
+28.28%
CURRENT VS 15Y AVG
+47.78%
CURRENT VS 20Y AVG
+72.40%
SECTOR MEDIAN · HEALTHCARE
0.00%
median of 509 covered companies
CURRENT VS SECTOR MEDIAN
N/A
vs the sector median at left
AxoGen, Inc.
Market Cap
$2.00B
Net Profit Margin
-13.36%
TTM Avg
-10.76%
3Y Avg
-9.31%
5Y Avg
-13.79%
Market Cap
$1.99B
Net Profit Margin
-7756.37%
TTM Avg
-3193.87%
3Y Avg
-2536.69%
5Y Avg
-2093.05%
Market Cap
$2.01B
Net Profit Margin
-20.02%
TTM Avg
-19.08%
3Y Avg
-29.38%
5Y Avg
-13.21%
Market Cap
$2.03B
Net Profit Margin
100.84%
TTM Avg
51.96%
3Y Avg
-5.31%
5Y Avg
-103.82%
Market Cap
$1.97B
Net Profit Margin
-15.82%
TTM Avg
-37.57%
3Y Avg
-42.30%
5Y Avg
-41.11%
Market Cap
$2.04B
Net Profit Margin
-3059.99%
TTM Avg
-3150.18%
3Y Avg
-1765.57%
5Y Avg
-1177.05%
Market Cap
$2.05B
Net Profit Margin
-36.51%
TTM Avg
-21.30%
3Y Avg
-316.14%
5Y Avg
-299.31%
Market Cap
$2.06B
Net Profit Margin
15.03%
TTM Avg
11.31%
3Y Avg
2.06%
5Y Avg
-9.89%
Market Cap
$2.07B
Net Profit Margin
-40.90%
TTM Avg
5.22%
3Y Avg
-37.29%
5Y Avg
-215.44%
| NAME | MARKET CAP | NET PROFIT MARGIN | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| AxoGen, Inc. (AXGN) | $2.00B | -13.36% | -10.76% | -9.31% | -13.79% |
| Absci Corporation (ABSI)vs › | $1.99B | -7756.37% | -3193.87% | -2536.69% | -2093.05% |
| Azenta, Inc. (AZTA)vs › | $2.01B | -20.02% | -19.08% | -29.38% | -13.21% |
| Aurinia Pharmaceuticals Inc. (AUPH)vs › | $2.03B | 100.84% | 51.96% | -5.31% | -103.82% |
| Establishment Labs Holdings Inc. (ESTA)vs › | $1.97B | -15.82% | -37.57% | -42.30% | -41.11% |
| Immunome, Inc. (IMNM)vs › | $2.04B | -3059.99% | -3150.18% | -1765.57% | -1177.05% |
| Alvotech (ALVO)vs › | $2.05B | -36.51% | -21.30% | -316.14% | -299.31% |
| Inspire Medical Systems, Inc. (INSP)vs › | $2.06B | 15.03% | 11.31% | 2.06% | -9.89% |
| BioCryst Pharmaceuticals, Inc. (BCRX)vs › | $2.07B | -40.90% | 5.22% | -37.29% | -215.44% |
| Fortrea Holdings Inc. (FTRE)vs › | $2.09B | -3.18% | -24.20% | -10.68% | -8.90% |
Operating Margin
-5.1%
Net Profit Margin
-13.4%
Net Profit Margin = Net Income / Revenue
Net profit margin is the percentage of revenue that becomes net income after all expenses, taxes, and interest.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | NET PROFIT MARGIN |
|---|---|
| 2026-06-30 | -2.17% |
| 2026-03-31 | -31.87% |
| 2025-12-31 | -21.96% |
| 2025-09-30 | 1.18% |
| 2025-06-30 | 1.02% |
| 2025-03-31 | -7.90% |
| 2024-12-31 | 0.91% |
| 2024-09-30 | -3.82% |
| 2024-06-30 | -4.01% |
| 2024-03-31 | -16.04% |
| 2023-12-31 | -9.07% |
| 2023-09-30 | -9.91% |
| 2023-06-30 | -17.46% |
| 2023-03-31 | -19.29% |
| 2022-12-31 | -14.97% |
| 2022-09-30 | -11.68% |
| 2022-06-30 | -22.46% |
| 2022-03-31 | -37.01% |
| 2021-12-31 | -16.76% |
| 2021-09-30 | -22.88% |
| 2021-06-30 | -23.52% |
| 2021-03-31 | -21.46% |
| 2020-12-31 | -18.50% |
| 2020-09-30 | -4.42% |
| 2020-06-30 | -36.65% |
| 2020-03-31 | -33.77% |
| 2019-12-31 | -24.99% |
| 2019-09-30 | -19.50% |
| 2019-06-30 | -26.30% |
| 2019-03-31 | -40.82% |
| 2018-12-31 | -22.31% |
| 2018-09-30 | -18.10% |
| 2018-06-30 | -36.08% |
| 2018-03-31 | -32.67% |
| 2017-12-31 | -14.73% |
| 2017-09-30 | -13.24% |
| 2017-06-30 | -13.58% |
| 2017-03-31 | -30.73% |
| 2016-12-31 | -49.32% |
| 2016-09-30 | -20.57% |
| 2016-06-30 | -27.00% |
| 2016-03-31 | -45.32% |
| 2015-12-31 | -46.24% |
| 2015-09-30 | -36.53% |
| 2015-06-30 | -49.73% |
| 2015-03-31 | -72.21% |
| 2014-12-31 | -135.40% |
| 2014-09-30 | -69.32% |
| 2014-06-30 | -88.78% |
| 2014-03-31 | -135.12% |
| 2013-12-31 | -137.65% |
| 2013-09-30 | -120.16% |
| 2013-06-30 | -120.82% |
| 2013-03-31 | -160.43% |
| 2012-12-31 | -197.65% |
| 2012-09-30 | -112.92% |
| 2012-06-30 | -51.17% |
| 2012-03-31 | -127.59% |
| 2011-12-31 | -156.90% |
| 2011-09-30 | -272.83% |
| 2011-06-30 | -136.98% |
| 2011-03-31 | -204.19% |
| 2010-12-31 | -890.55% |
| 2010-09-30 | -117.77% |
| 2010-06-30 | -7080.15% |
| 2010-03-31 | -1259.30% |
| 2009-12-31 | 62.61% |
| 2009-09-30 | -540.88% |
| 2009-06-30 | 22.77% |
| 2009-03-31 | -319.33% |
| 2008-12-31 | -371.33% |
| 2008-09-30 | -4156.60% |
| 2008-06-30 | -3487.68% |
| 2008-03-31 | -760.85% |
| 2007-12-31 | 0.00% |
| 2007-09-30 | 0.00% |
| 2007-06-30 | 0.00% |
| 2007-03-31 | 0.00% |
| 2006-12-31 | 0.00% |
| 2006-09-30 | -180.10% |
| 2006-06-30 | 0.00% |
| 2006-03-31 | -55.89% |
| 2005-12-31 | 54.92% |
| 2005-09-30 | 0.55% |
| 2005-06-30 | -210.09% |
| 2005-03-31 | -723.28% |
| 2004-12-31 | 0.00% |
| 2004-09-30 | 108.64% |
| 2004-06-30 | 0.58% |
| 2004-03-31 | 3.01% |
| 2003-12-31 | -7.29% |
| 2003-09-30 | -17.39% |
| 2003-06-30 | -26.72% |
| 2003-03-31 | -21.81% |
| 2002-12-31 | -37.79% |
| 2002-09-30 | -18.37% |
